HSIF02 · House Subcommittee

Oversight and Investigations Subcommittee

House Energy and Commerce Subcommittee on Oversight and Investigations

Showing the 115th Congress (2017–2018). Back to the 119th Congress

0 bills referred in the 115th Congress

1 across the 1 Congress on file, most in the 111th at 1. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 111th to 111th

Members
20

Served in the 115th Congress

Meetings
29

Hearings and business meetings in the 115th Congress

Members, 115th Congress 20

Everyone listed on the subcommittee in the 115th Congress, from printed hearings, the Congressional Directory and the official rosters.

Record

Bills, meetings, hearings, reports and more, newest first. In the 115th Congress.

Hearings, markups and business meetings, newest first. In the 115th Congress.

KindSubjectStatusDate
HearingConcerns Over Federal Select Agent Program Oversight of Dangerous PathogensRayburn House Office Building 2322
3 witnesses
  • Dr. Samuel Edwin, Director, Division of Select Agents and Toxins, Centers for Disease Control and Prevention
  • Dr. Freeda Isaac, Director, Agriculture Select Agent Services, Animal and Plant Health Inspection Service
  • Dr. Mary Denigan-Macauley, Acting Director, Health Care, Government Accountability Office
RescheduledNov 2, 2017
HearingExamining HHS’s Public Health Preparedness for and Response to the 2017 Hurricane SeasonRayburn House Office Building 2123
4 witnesses
  • The Honorable Robert Kadlec, MD, Assistant Secretary for Preparedness and Response, Department of Health and Human Services
  • The Honorable Scott Gottlieb, MD, Commissioner, U.S. Food and Drug Administration
  • Ms. Kimberly Brandt, Principal Deputy Administrator for Operations, Centers for Medicare and Medicaid Services
  • Rear Admiral Upper Half Stephen Redd, MD, Director of the Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention
ScheduledOct 24, 2017
HearingExamining How Covered Entities Utilize the 340B Drug Pricing ProgramRayburn House Office Building 2123
5 witnesses
  • Ms. Sue Veer, President and CEO, Carolina Health Centers, Inc.
  • Mr. Mike Gifford, President and CEO, AIDS Resource Center of Wisconsin
  • Dr. Ronald Paulus, President and CEO, Mission Health Systems, Inc.
  • Mr. Charles Reuland, Executive Vice President and COO, Johns Hopkins Hospital
  • Ms. Shannon Banna, Director of Finance and System Controller, Northside Hospital, Inc.
ScheduledOct 11, 2017
HearingEPA Oversight: Unimplemented Inspector General and GAO RecommendationsRayburn House Office Building 2322
2 witnesses
  • Mr. Alan Larsen, Counsel to the Inspector General, U.S. Environmental Protection Agency
  • Mr. Alfredo Gómez, Director of Natural Resources and Environment, Government Accountability Office
ScheduledSep 6, 2017
HearingExamining HRSA’s Oversight of the 340B Drug Pricing ProgramRayburn House Office Building 2322
3 witnesses
  • Debra Draper, Director, Health Care, Government Accountability Office
  • Erin Bliss, Assistant Inspector General, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
  • Captain Krista Pedley, Director, Office of Pharmacy Affairs, Health Resources and Services Administration, U.S. Department of Health and Human Services
ScheduledJul 18, 2017
HearingCombating the Opioid Crisis: Battles in the StatesRayburn House Office Building 2123
4 witnesses
  • The Honorable Boyd Rutherford, Lieutenant Governor, State of Maryland
  • The Honorable Brian Moran, Secretary of Public Safety and Homeland Security, State of Virginia
  • The Honorable Rebecca Boss, Director, Department of Behavioral Healthcare, Developmental Disabilities and Hospitals, State of Rhode Island
  • The Honorable John Tilley, Secretary of the Justice and Public Safety Cabinet, State of Kentucky
ScheduledJul 12, 2017
HearingExamining the Role of the Department of Health and Human Services in Health Care CybersecurityRayburn House Office Building 2322
3 witnesses
  • Mr. Leo Scanlon, Deputy Chief Information Security Officer, U.S. Department of Health and Human Services
  • Mr. Steve Curren, Director, Division of Resilience, Office of Emergency Management, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
  • Mr. Emery Csulak, Chief Information Security Officer and Senior Privacy Official, Centers for Medicare and Medicaid Services, Co-Chair, Health Care Industry Cybersecurity Task Force
ScheduledJun 8, 2017
HearingU.S. Public Health Response to the Zika Virus: Continuing ChallengesRayburn House Office Building 2123
5 witnesses
  • Dr. Timothy Persons, Chief Scientist, U.S. Government Accountability Office
  • Dr. Lyle Petersen, Director, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
  • Dr. Luciana Borio, Acting Chief Scientist, U.S. Food and Drug Administration
  • Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Dr. Rick Bright, Director, Biomedical Advanced Research and Development Authority; Deputy Assistant Secretary, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
ScheduledMay 23, 2017

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

CongressMembersBills referredBecame lawMeetings
119th2025–2026, sitting200011
118th2023–2024170027
117th2021–2022190017
116th2019–2020190021
115th2017–2018200029
114th2015–2016240020
113th2013–2014270017
112th2011–201225000
111th2009–20102111—
110th2007–20081700—
109th2005–20061600—
108th2003–20041900—
107th2001–20021700—

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. A subcommittee's referrals are recorded against it separately from its parent's, so the two lists do not add up. Records come from Congress.gov, GovInfo and the House and Senate.